Trials / Unknown
UnknownNCT02391142
Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- First Affiliated Hospital of Harbin Medical University · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of Cardiac Sympathetic Blockade on Mortality, re-hospitalization rate, symptoms, quality of life, exercise tolerance, cardiac structure, systolic function, electrical activities and concentration of B - type natriuretic peptide precursor in patients with Chronic Heart Failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lidocaine | 0.5% lidocaine 5ml epidural injection every 2 hours per day or 0.2% ropivacaine 5ml epidural injection every 4 hours per day, last for 4weeks |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2018-12-01
- Completion
- 2019-01-01
- First posted
- 2015-03-18
- Last updated
- 2018-08-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02391142. Inclusion in this directory is not an endorsement.